SK79797A3 - Piperazine derivatives, medicaments containing the same, their use and process for preparing the same - Google Patents

Piperazine derivatives, medicaments containing the same, their use and process for preparing the same Download PDF

Info

Publication number
SK79797A3
SK79797A3 SK797-97A SK79797A SK79797A3 SK 79797 A3 SK79797 A3 SK 79797A3 SK 79797 A SK79797 A SK 79797A SK 79797 A3 SK79797 A3 SK 79797A3
Authority
SK
Slovakia
Prior art keywords
group
alkyl
piperidinyl
piperazin
acid
Prior art date
Application number
SK797-97A
Other languages
English (en)
Slovak (sk)
Inventor
Helmut Pieper
Volkhard Austel
Frank Himmelsbach
Gunter Linz
Brian Guth
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19944446301 external-priority patent/DE4446301A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SK79797A3 publication Critical patent/SK79797A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK797-97A 1994-12-23 1995-12-19 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same SK79797A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19944446301 DE4446301A1 (de) 1994-12-23 1994-12-23 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19526678A DE19526678A1 (de) 1994-12-23 1995-07-21 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE1995133639 DE19533639A1 (de) 1994-12-23 1995-09-12 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP1995/005031 WO1996020173A1 (de) 1994-12-23 1995-12-19 Piperazinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SK79797A3 true SK79797A3 (en) 1997-11-05

Family

ID=27207101

Family Applications (1)

Application Number Title Priority Date Filing Date
SK797-97A SK79797A3 (en) 1994-12-23 1995-12-19 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same

Country Status (20)

Country Link
US (1) US5922717A (bg)
EP (1) EP0799202A1 (bg)
JP (1) JPH10511374A (bg)
CN (1) CN1183770A (bg)
AR (1) AR002950A1 (bg)
AU (1) AU4432496A (bg)
BG (1) BG101582A (bg)
BR (1) BR9510360A (bg)
CA (1) CA2207618A1 (bg)
CZ (1) CZ189197A3 (bg)
EE (1) EE9700141A (bg)
FI (1) FI972646A (bg)
HR (1) HRP950609A2 (bg)
IL (1) IL116517A0 (bg)
MX (1) MX9704745A (bg)
NO (1) NO972881D0 (bg)
PL (1) PL321003A1 (bg)
SK (1) SK79797A3 (bg)
TR (1) TR199501634A2 (bg)
WO (1) WO1996020173A1 (bg)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796098A4 (en) * 1994-12-22 1998-04-29 Smithkline Beecham Corp FIBRINOGEN RECEPTOR ANTAGONISTS
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
JPH11513382A (ja) * 1995-10-20 1999-11-16 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング ５員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO1999052894A1 (fr) * 1998-04-09 1999-10-21 Meiji Seika Kaisha, Ltd. Composes heterocycliques a base d'azote anti-agregation plaquettaire et leur utilisation medicale
EP1533310A1 (en) * 1999-09-29 2005-05-25 Ortho-McNeil Pharmaceutical, Inc. Isonipecotamides for the treatment of integrin-mediated disorders
BR0007183A (pt) * 1999-09-29 2002-02-05 Ortho Mcneil Pharm Inc Isonipectoamidas para o tratamento de distúrbios mediados por integrina
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
DE60208186T2 (de) * 2001-04-09 2006-08-24 Ortho-Mcneil Pharmaceutical Research Inc. Chinazolin- und chinazolinähnliche verbindungen zur behandlung von integrin-vermittelten erkrankungen
JP2005504771A (ja) 2001-08-24 2005-02-17 エール ユニヴァーシティ 抗腫瘍・抗癌剤としてのピペラジノン化合物と処置方法
FR2829766A1 (fr) * 2001-09-14 2003-03-21 Lipha Derives d'oxamates comportant un heterocycle azote diversement substitue
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
US7482365B2 (en) 2002-02-08 2009-01-27 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
EP1737809B1 (en) * 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
CA2606004A1 (en) * 2005-08-02 2007-02-08 Neurogen Corporation Dipiperazinyl ketones and related analogues
JP5175736B2 (ja) 2005-10-28 2013-04-03 メルク・シャープ・エンド・ドーム・コーポレイション ピペリジングリシン輸送体阻害剤
SI2041088T1 (sl) 2006-06-28 2014-05-30 Amgen Inc. Inhibitorji transporter-1 glicina
WO2008013622A2 (en) * 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
SI2076506T1 (sl) * 2007-01-16 2011-01-31 Purdue Pharma Lp Heterociklično substituirani piperidini kot ORL-1 ligandi
EP3101018B1 (en) 2007-08-31 2019-03-06 Purdue Pharma L.P. Substituted-quinoxaline-type-piperidine compounds and the uses thereof
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
AU2012272898A1 (en) 2011-06-24 2013-04-11 Amgen Inc. TRPM8 antagonists and their use in treatments
US8710043B2 (en) 2011-06-24 2014-04-29 Amgen Inc. TRPM8 antagonists and their use in treatments
US9255086B2 (en) 2012-02-16 2016-02-09 New York University Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CA2898329A1 (en) 2013-01-19 2014-07-24 New York University Oligooxopiperazines for p53 reactivation
WO2015179547A2 (en) 2014-05-21 2015-11-26 New York University Oxopiperazine helix mimetics for control of hypoxia-inducible gene expression
WO2023122481A2 (en) * 2021-12-20 2023-06-29 Sigma-Aldrich Co. Llc Chemical linkers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2926472A1 (de) * 1979-06-30 1981-01-15 Thomae Gmbh Dr K Neue benzoylderivate, deren herstellung und deren verwendung als arzneimittel
ZA825719B (en) * 1981-09-03 1983-06-29 Recordati Chem Pharm Alkanoylanilides
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
US4895846A (en) * 1984-04-11 1990-01-23 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
DE4035961A1 (de) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4332168A1 (de) * 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE69411900T2 (de) * 1993-03-29 1998-12-10 Zeneca Ltd., London Heterozyklische derivate als plätchenaggregationsinhibitoren
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
DE4324580A1 (de) * 1993-07-22 1995-01-26 Thomae Gmbh Dr K Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4326344A1 (de) * 1993-08-05 1995-02-09 Thomae Gmbh Dr K Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP0721941A4 (en) * 1994-07-15 1996-09-25 Meiji Seika Co NOVEL COMPOUNDS HAVING AN INHIBITING EFFECT ON PLATELET AGGREGATION
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives

Also Published As

Publication number Publication date
BR9510360A (pt) 1997-12-23
WO1996020173A1 (de) 1996-07-04
CN1183770A (zh) 1998-06-03
NO972881L (no) 1997-06-20
CZ189197A3 (cs) 1998-01-14
IL116517A0 (en) 1996-03-31
HRP950609A2 (en) 1997-10-31
PL321003A1 (en) 1997-11-24
AR002950A1 (es) 1998-05-27
NO972881D0 (no) 1997-06-20
BG101582A (bg) 1998-01-30
US5922717A (en) 1999-07-13
EP0799202A1 (de) 1997-10-08
EE9700141A (et) 1997-12-15
FI972646A0 (fi) 1997-06-19
CA2207618A1 (en) 1996-07-04
TR199501634A2 (tr) 1996-07-21
AU4432496A (en) 1996-07-19
JPH10511374A (ja) 1998-11-04
FI972646A (fi) 1997-08-19
MX9704745A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
SK79797A3 (en) Piperazine derivatives, medicaments containing the same, their use and process for preparing the same
US5700801A (en) Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
US5994356A (en) Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
US5719156A (en) Piperazino derivatives as neurokinin antagonists
US5883096A (en) Muscarinic antagonists
SK107293A3 (en) Carboxylic acid derivatives, drugs containing these compounds and method of their production
EP1587795B1 (de) N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivate und verwandte verbindungen als cgrp-antagonisten zur behandlung von kopfschmerzen
US4791102A (en) Derivatives of the N α-arylsulphonylaminoacyl-p-amidinophenylalaninamides, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
AU2011311530B2 (en) Co-crystals and salts of CCR3-inhibitors
EA018046B1 (ru) Сульфониламидные производные в качестве антагонистов брадикининовых рецепторов, их получение и фармацевтическая композиция, их содержащая
WO1995022525A1 (en) N-acylpiperidine tachykinin antagonists
US20100087423A1 (en) New benzamide derivatives as bradykinin antagonists
US6239126B1 (en) Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
US6103719A (en) Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds
EP2539706B1 (en) Arylpiperazine opioid receptor antagonists
US6395753B1 (en) Cyclic amine compounds and pharmaceutical composition containing the same
DE19533639A1 (de) Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US5057524A (en) 4-[diaryl)hydroxymethyl]-1-piperidinealkylcarboxylic acids, salts and esters useful in the treatment of allergic disorders
SK282232B6 (sk) Fenylamidíny, ich fyziologicky prijateľné soli, farmaceutický prostriedok s ich obsahom, spôsob ich výroby a ich použitie
US4364954A (en) Diphenylpropanamines, compositions thereof and use thereof
DE19607436A1 (de) Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CA2244860A1 (en) Carboxylic acid derivatives with an aggregation-inhibiting action
DE19533224A1 (de) Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung